Merrimack Pharmaceuticals Price History

MACKDelisted Stock  USD 11.96  0.12  1.01%   
If you're considering investing in Merrimack Stock, it is important to understand the factors that can impact its price. As of today, the current price of Merrimack Pharmaceuticals stands at 11.96, as last reported on the 23rd of November, with the highest price reaching 12.01 and the lowest price hitting 11.84 during the day. We have found twenty-four technical indicators for Merrimack Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please verify Merrimack Pharmaceuticals' Mean Deviation of 0.7806, risk adjusted performance of (0.03), and Standard Deviation of 1.12 to check out if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Merrimack Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
MACK
Based on monthly moving average Merrimack Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Merrimack Pharmaceuticals by adding Merrimack Pharmaceuticals to a well-diversified portfolio.

Merrimack Pharmaceuticals Stock Price History Chart

There are several ways to analyze Merrimack Stock price data. The simplest method is using a basic Merrimack candlestick price chart, which shows Merrimack Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.

Merrimack Stock Price History Data

The price series of Merrimack Pharmaceuticals for the period between Sun, Aug 25, 2024 and Sat, Nov 23, 2024 has a statistical range of 1.47 with a coefficient of variation of 2.85. The daily prices for the period are spread out with arithmetic mean of 12.33. The median price for the last 90 days is 12.43. The company underwent 1271:1000 stock split on 6th of September 2019. Merrimack Pharmaceuticals issued dividends to stockholders on 2024-05-09.
OpenHighLowCloseVolume
11/23/2024
 11.84  12.01  11.84  11.96 
07/24/2023 11.84  12.01  11.84  11.96  54,859 
07/21/2023 11.69  12.02  11.58  11.89  80,350 
07/20/2023 11.60  11.72  11.60  11.67  53,327 
07/19/2023 11.68  11.68  11.53  11.60  84,448 
07/18/2023 11.72  11.74  11.56  11.65  62,578 
07/17/2023 11.65  11.84  11.65  11.74  58,938 
07/14/2023 11.62  11.74  11.62  11.68  66,668 
07/13/2023 11.72  11.89  11.72  11.86  70,151 
07/12/2023 11.83  11.83  11.68  11.69  105,792 
07/11/2023 11.70  11.80  11.70  11.75  78,792 
07/10/2023 11.85  11.98  11.71  11.75  119,693 
07/07/2023 11.90  11.95  11.78  11.80  209,079 
07/06/2023 11.99  12.09  11.87  11.88  196,886 
07/05/2023 12.22  12.33  12.10  12.10  100,144 
07/03/2023 12.31  12.41  12.28  12.29  56,435 
06/30/2023 12.30  12.39  12.22  12.30  380,900 
06/29/2023 12.01  12.76  12.00  12.31  350,716 
06/28/2023 12.10  12.18  12.00  12.02  122,604 
06/27/2023 12.15  12.25  12.04  12.07  194,413 
06/26/2023 12.31  12.35  12.14  12.19  273,093 
06/23/2023 12.40  12.49  12.23  12.36  1,096,145 
06/22/2023 12.26  12.51  12.26  12.40  107,987 
06/21/2023 12.41  12.49  12.36  12.36  74,602 
06/20/2023 12.40  12.54  12.36  12.44  55,110 
06/16/2023 12.36  12.52  12.36  12.46  81,250 
06/15/2023 12.42  12.52  12.30  12.39  134,502 
06/14/2023 12.50  12.64  12.41  12.43  57,682 
06/13/2023 12.55  12.59  12.50  12.54  59,936 
06/12/2023 12.50  12.62  12.48  12.50  41,200 
06/09/2023 12.47  12.56  12.45  12.53  48,184 
06/08/2023 12.40  12.57  12.40  12.48  53,027 
06/07/2023 12.43  12.59  12.41  12.45  55,300 
06/06/2023 12.60  12.60  12.40  12.48  65,337 
06/05/2023 12.65  12.65  12.51  12.51  29,803 
06/02/2023 12.68  12.70  12.58  12.62  55,017 
06/01/2023 12.47  12.78  12.47  12.67  32,948 
05/31/2023 12.53  12.53  12.40  12.52  19,022 
05/30/2023 12.50  12.70  12.37  12.52  56,489 
05/26/2023 12.55  12.55  12.29  12.50  54,967 
05/25/2023 12.45  12.46  12.20  12.46  58,779 
05/24/2023 12.46  12.50  12.29  12.47  35,153 
05/23/2023 12.58  12.66  12.28  12.43  126,538 
05/22/2023 12.71  12.86  12.52  12.65  47,490 
05/19/2023 12.77  12.88  12.64  12.72  45,421 
05/18/2023 12.81  12.88  12.62  12.77  59,542 
05/17/2023 12.76  12.88  12.76  12.82  36,424 
05/16/2023 12.76  12.89  12.66  12.81  80,036 
05/15/2023 12.44  12.83  12.44  12.77  53,574 
05/12/2023 12.49  12.65  12.44  12.50  44,767 
05/11/2023 12.39  12.60  12.39  12.53  28,578 
05/10/2023 13.08  13.13  12.31  12.44  180,035 
05/09/2023 13.00  13.08  12.91  13.07  192,389 
05/08/2023 12.81  13.02  12.79  13.00  113,768 
05/05/2023 12.31  12.74  12.31  12.72  57,629 
05/04/2023 12.52  12.76  12.48  12.62  44,226 
05/03/2023 12.88  12.92  12.42  12.55  81,987 
05/02/2023 12.61  12.89  12.44  12.79  87,947 
05/01/2023 12.49  12.64  12.36  12.59  51,957 
04/28/2023 12.31  12.55  12.30  12.41  110,123 
04/27/2023 12.17  12.39  12.12  12.32  47,359 

About Merrimack Pharmaceuticals Stock history

Merrimack Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Merrimack is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Merrimack Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Merrimack Pharmaceuticals stock prices may prove useful in developing a viable investing in Merrimack Pharmaceuticals
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts. Merrimack Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.

Merrimack Pharmaceuticals Stock Technical Analysis

Merrimack Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Merrimack Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Merrimack Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Price Exposure Probability Now

   

Price Exposure Probability

Analyze equity upside and downside potential for a given time horizon across multiple markets
All  Next Launch Module

Merrimack Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Merrimack Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Merrimack Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Merrimack to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Consideration for investing in Merrimack Stock

If you are still planning to invest in Merrimack Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Merrimack Pharmaceuticals' history and understand the potential risks before investing.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA